Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin 2 regulation following semi-allogeneic bone marrow transplantation in mice.

Cancer immunology, immunotherapy : CII - 1 Nov 2006

Abdul-Hai Ali, Ben-Yehuda Arie, Galsky Haya, Slavin Shimon, Or Reuven

Abstract excerpt

Success of allogeneic and autologous bone marrow transplantation (BMT) is hampered by susceptibility to infection during the first two post-treatment years. Further, in treating malignant diseases, impaired anti-host reactivity for donor cells may contribute to a high rate of relapse. Both complications are a consequence of immune deficiency involving B and T lymphocytes. The present study evaluates several key...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow Transplantation
Share to Immune System

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Interleukin-2

Share to Mice, Inbred BALB C

Share to Spleen

Share to T-Lymphocytes

Share to Thymus Gland

Share to Transplantation, Homologous

Source

Open in PubMed Open full text

Identifiers

PMID: 16450143
DOI: 10.1007/s00262-006-0125-y
PMCID: PMC11030658

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin 2 regulation following semi-allogeneic bone marrow transplantation in mice.PMID 16450143Read ↗

Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells.Semantic proximity Read ↗

Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.Semantic proximity Read ↗

Interleukin-22 Aggravates Murine Acute Graft-Versus-Host Disease by Expanding Effector T Cell and Reducing Regulatory T CellSemantic proximity Read ↗

B-cell immunity after allogeneic hematopoietic cell transplantation.Semantic proximity Read ↗

Immunological reconstitution following bone marrow transplantationSemantic proximity Read ↗

Interleukin-2 after autologous bone marrow transplantation as consolidative immunotherapy against minimal residual disease.Semantic proximity Read ↗

Disease severity and mortality can be independently regulated in a mouse model of experimental graft versus host disease.Semantic proximity Read ↗

Hematopoietic stem cell functional failure in interleukin-2-deficient mice.Semantic proximity Read ↗

Prevention of graft-versus-host disease (GVHD) by elimination of recipient-reactive donor T cells with recombinant toxins that target the interleukin 2 (IL-2) receptor.Semantic proximity Read ↗

Alteration of the T cell repertoire after bone marrow transplantation.Semantic proximity Read ↗

Pneumonitis in bone marrow transplant recipients results from a local immune response.Semantic proximity Read ↗

Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.